Why Estee Lauder (EL) Could Beat Earnings Estimates Again

The Estée Lauder Companies (EL) has delivered consecutive upside earnings surprises, averaging a 33.06% beat over the last two quarters (most recently $1.89 EPS vs. $1.67 consensus, a 13.17% surprise; prior quarter $0.78 vs. $0.51, a 52.94% surprise). Zacks reports a positive Earnings ESP of +0.13% and a Zacks Rank #3 (Hold), a combination historically associated with ~70% probability of a quarterly beat, and the next earnings release is expected on February 3, 2022. This mix of recent upside, modest upward analyst revisions and favorable ESP suggests a higher likelihood of another earnings beat, which may influence short-term investor positioning in the stock.

Analysis

Market structure: Estee Lauder (EL) is positioned to benefit from repeat earnings beats (two-quarter avg. EPS surprise ~33%) which reinforces pricing power in prestige beauty and travel-retail channels; winners include premium brand peers, packaging suppliers and retailers with luxury footprints, while mass-market players face share pressure. Strong estimate revisions (Earnings ESP +0.13%) imply demand resilience; if guidance confirms continued China/travel rebound, expect upward re-rating of luxury cosmetics vs. broader consumer staples over 3–12 months. Cross-asset: a clean beat will be risk-on—equities bid, IG credit spreads tighten 10–20bp, USD may soften modestly; options IV should collapse 20–40% post-print, favoring directional option buyers who hedge timing.

Risk assessment: Tail risks include a China setback or travel-retail slowdown, raw-material cost spikes (fragrance/raw materials) and sudden FX hedging losses; quantify triggers as >300bp margin hit or China sales miss >5% y/y. Immediate (days): earnings surprise drives volatility; short-term (weeks) sentiment/IV normalization dominates; long-term (quarters) rests on brand innovation and margin mix. Hidden dependencies: recent analyst revisions may be skewed by buybacks, one-off tax/benefit items or inventory draws; catalyst list centers on Feb 3 earnings, management guide and China sales cadence.

Trade implications: Direct: tactical long EL equity or buy call spreads into Feb 3, but size 1–2% portfolio and expect a 5–12% move on beat. Pair: long EL vs short COTY (COTY) for 3-month relative-strength trade betting on execution/margin dispersion. Options: prefer 30–60 day call spreads initiated 5–10 days pre-earnings to cap cost; avoid naked short gamma into print. Sector rotation: trim cyclicals and reallocate 1–3% to luxury consumer names if EL guidance confirms China recovery; use stops and IV-aware exits.

Contrarian angles: Consensus focuses on near-term EPS beats; it may underweight margin pressure from promotional activity or input-cost creep—beats can still coincide with weak revenue quality. The market often “buys the rumor, sells the news”; expect a high chance (40–60%) of post-beat pullback as IV collapses even if fundamentals improve. Historical parallels: prior stretch of consecutive beats in beauty led to multi-quarter outperformance but left the name vulnerable to macro downticks; avoid full conviction until several quarters of sustained top-line improvement confirm de-leveraging of fixed costs.

Key Decisions for Investors

• Establish a 1–2% long position in EL equity ahead of the Feb 3 earnings call (or equivalent next print), with a hard stop at -8% and a profit target to trim at +12% within 5–10 trading days post-release; increase only if guidance raises full-year margins by ≥100bps.
• If limited risk tolerance, buy a 30–60 day EL call spread sized to 0.5–1% of portfolio (buy ATM, sell 10–15% OTM) initiated 5–10 days pre-earnings; close within 3 trading days after earnings or on a +75–100% options P&L.
• Run a 3-month pair trade: long EL (1% portfolio) vs short COTY (0.5–1%) to express expected margin/execution divergence; rebalance or close if spread narrows by 30% or if EL’s China revenue share guidance misses by >5% y/y.
• Reduce broad cyclical consumer exposure by 1–3% and rotate into luxury consumer names (EL, other prestige brands) only after confirmation of China/travel sales recovery in guidance or a durable >100bp improvement in gross margin guidance over the next two quarters.